Document is current
Any future updates will be listed below
-
Authors
Tang, Yumei
Lei, Ye
Gao, Peng
Jia, Junting
Du, Huijun
Wang, Qitong
Yan, Zhixin
Zhang, Chen
Liang, Guojun
Wang, Yanfeng
Ma, Weijun
Xing, Nianzeng
Cheng, Le
Ren, Laifeng
-
Funding
Funding for this research was provided by:
the Youth Project of National Natural Science Foundation of China (No. 82002702)
the Project funded by China Postdoctoral Science Foundation (No. 2022M710452)
the Youth Project of Natural Science Foundation of Hunan Science (No. 2020JJ5905)
the Doctoral Research Start-up Fund from Shanxi Province Cancer Hospital and Research Institute (No. 2017A08)
National Key R&D Program of China (No. 2022YFE0200800)
the National Natural Science Foundation of China (No. 81772700 & 81972400)
Yunnan High-level Talent Training Support Program, special project for industrial technology leading talents (2021, Yunnan Development and Reform Commission)
Major Science and Technology Projects of Yunnan Province (202002AA100007，202102AA100019)
the Key Research and Development (R&D) Projects of Shanxi Province (No. 201703D321013)
the Construction Project of Tumor Immunology Innovation Team of Shanxi Cancer Hospital
- License Information
-
More Information
Article History
Received: 10 November 2022
Accepted: 20 March 2023
First Online: 10 April 2023
Declarations
:
: This study was approved by the Ethics Committee of Shanxi Province Cancer Hospital (approval number, 202225) and Shanghai Outdo Biotech Company (approval number, YB M-05–01) including written informed consent provided by all patients/their legal guardians to participate in this study. The procedures were carried out under the principles expressed in the Declaration of Helsinki.
: Not applicable.
: There is no conflict of interest in publishing this manuscript.
